BP, AstraZeneca Settle Suit Over Seed IP Sale

Law360, New York (April 26, 2011, 8:25 PM EDT) -- Oil giant BP America Inc. on Tuesday settled a suit it filed in Missouri against an AstraZeneca PLC subsidiary over who should cover the cost of litigation arising from a now-defunct BP unit's deal to sell seed-related intellectual property.

The case — filed by BP over a 21-year-old deal to sell IP to a company that became an AstraZeneca Holdings BV subsidiary — is over, U.S. District Judge Judge E. Richard Webber said in an order closing the two-old action.

“All claims are dismissed with prejudice,”...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.